Grants and funding for social organisations
- 21187
- open calls
- 9
- countries
- 15
- official sources
We bring together public funding calls from Spain, the European Union and other countries in one place. Each listing shows the amount, the real deadline and who can apply, so you can tell at a glance whether your organisation fits.
Grants by organisation type
Open calls
Results update automatically as you type
21,187 calls · sorted by Closing soonest
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
United States · US
Who can apply Special district governments · Private institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized) · County governments · Independent school districts · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · City or township governments · State governments · Small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses
Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards are designed to mature experimental nanomedicines relying on nanoparticles and nano-devices which demonstrate strong potential to improve cancer treatment effectiveness due to the combination of nanoparticle/nano-device structural design and/or therapeutic/diagnostic cargo which is delivered. TTNCI awards are expected to enable further development of proposed nanotechnology-based interventions to the stage in which they could continue on a developmental path towards the NCI Experimental Therapeutics (NExT) and other NCI translational programs.
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
United States · US
Who can apply Native American tribal governments (Federally recognized) · State governments · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Special district governments · Native American tribal organizations (other than Federally recognized tribal governments) · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · County governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Independent school districts · Public housing authorities/Indian housing authorities · For profit organizations other than small businesses · Small businesses
This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities. These priorities were most recently outlined by the NIH Office of AIDS Research (OAR) in NOT-20-018, UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding, scientific priorities. Potential topics could address multiple overarching priorities. These include elucidation of unique pathophysiological mechanisms contributing to HIV comorbidities, coinfections, and complications (CCCs) affecting organs, tissues, and processes within the mission of the NIDDK. Likewise, interrogations into biological mechanisms underlying HIV reservoirs in NIDDK-relevant tissues are important for developing strategies for long-term viral suppression or eradication. Finally, health-impeding social determinants of health may affect CCCs or viral reservoirs within NIDDK's mission through multiple pathways.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
United States · US
Who can apply State governments · Native American tribal governments (Federally recognized) · County governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public and State controlled institutions of higher education · Private institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Small businesses · Special district governments · Public housing authorities/Indian housing authorities · For profit organizations other than small businesses · City or township governments · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may be possible in the near future.Having an accurate screening test, as well as demonstrating the benefits of early intervention or treatment, are important criteria for including a condition on a newborn screening panel. This FOA defines a "high priority" condition as one where screening is not currently recommended, but infants with the condition would significantly benefit from early identification and treatment.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
United States · US
Who can apply Independent school districts · Special district governments · Private institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized) · Public housing authorities/Indian housing authorities · Native American tribal organizations (other than Federally recognized tribal governments) · County governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · State governments · Public and State controlled institutions of higher education · For profit organizations other than small businesses · City or township governments · Small businesses
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may be possible in the near future.Having an accurate screening test, as well as demonstrating the benefits of early intervention or treatment, are important criteria for including a condition on a newborn screening panel. This FOA defines a "high priority" condition as one where screening is not currently recommended, but infants with the condition would significantly benefit from early identification and treatment.
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
United States · US
Who can apply Private institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · State governments · Independent school districts · Public and State controlled institutions of higher education · Small businesses · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · County governments · City or township governments · For profit organizations other than small businesses · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Special district governments
This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biological/genetic bases of cancer health disparities, such as (1) mechanistic studies of biological factors associated with cancer health disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This NOFO is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
United States · US
Who can apply Public housing authorities/Indian housing authorities · State governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · County governments · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Independent school districts · For profit organizations other than small businesses · City or township governments · Native American tribal governments (Federally recognized) · Private institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Small businesses · Special district governments
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to elucidate a role for understudied proteins in rare disease. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s). A list of eligible proteins is provided and are members of druggable protein families that have a known association with a rare disease. This NOFO is intended to jumpstart research on understudied proteins that are associated with rare diseases and provide applicants with sufficient funding to perform basic biochemical and/or biological work to further the characterization of understudied proteins within the context of rare disease.
EIC Pre-accelerator - Widening
European Union · EU
EIC Pre-accelerator - Widening
Period: May 5, 2027 – —
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
United States · US
Who can apply Small businesses · State governments · Public and State controlled institutions of higher education · Native American tribal governments (Federally recognized) · Public housing authorities/Indian housing authorities · Independent school districts · For profit organizations other than small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · City or township governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · County governments · Private institutions of higher education · Special district governments
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.
DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
United States · US
Who can apply Others (see text field entitled "Additional Information on Eligibility" for clarification)
The purpose of this combined Broad Agency Announcement (BAA) under Federal Acquisition Regulation (FAR) Part 35 and Funding Opportunity Announcement (FOA) under 2 Code of Federal Regulations (CFR) 200.204 (henceforth referred to as “BAA”) is to solicit research proposals for submission to the U.S. Army Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL) for funding consideration. Prior to this announcement, ARL announced two separate BAAs to support the mission: 1) W911NF-17-S-0002 titled “Army Research Laboratory Army Research Office Broad Agency Announcement for Fundamental Research”; and 2) W911NF-17-S-0003 titled “Army Research Laboratory Broad Agency Announcement for Basic and Applied Scientific Research”. This announcement succeeds BAA W911NF-17-S-0002 and BAA W911NF-17-S-0003 combining the opportunities into a single announcement. ARL’s mission as the Army’s foundational research laboratory is to Operationalize Science to ensure overmatch in any future conflict. ARL’s foundational research mission spans basic research (budget activity 6.1) and applied research (budget activity 6.2) as defined by 32 CFR 22.105 but may include advanced technology development (budget activity 6.3) and advanced component development and prototypes (budget activity 6.4) when opportunities arise to directly or indirectly help achieve ARL’s mission. ARL partners across the national security enterprise to deliver fundamentally advantageous change that is rooted in the creation and exploitation of scientific knowledge. This publication constitutes a BAA for awards as contemplated in FAR 6.102(d)(2) and 35.016 as well as a merit-based, competitive procedure in accordance with the Department of Defense Grant and Agreement Regulations (DoDGARS) at 32 CFR 22.315(a) and the Office of the Under Secretary of Defense for Acquisition and Sustainment Other Transaction Guide version 2.0 dated July 2023. This BAA document, and the online list of research topics found on the ARL BAA topics website at https://www.arl.devcom.army.mil/opportunities/arl-baa/ , sets forth ARL’s research topics of interest for whitepapers and proposals. This BAA is issued under FAR 6.102(d)(2), which provides for the competitive selection of basic and applied research proposals, and 10 U.S.C. 4001, 10 U.S.C. 4021, and 10 U.S.C. 4022, which provide the authorities for issuing awards under this announcement for basic and applied research. The definitions of basic and applied research may be found at 32 CFR 22.105. Proposals submitted in response to this BAA and selected for award are considered to be the result of full and open competition and in full compliance with the provision of Public Law 98-369, “The Competition in Contracting Act of 1984” and subsequent amendments.
MSCA Doctoral Networks 2027
European Union · EU
MSCA Doctoral Networks 2027
Period: May 26, 2027 – —
INSTRUMENTAL CALL FOR INTERNATIONAL COOPERATION GRANT. Promotion of Sustainable Livelihoods in Dominican Bateyes through their cultural industries
ESTADO - MINISTERIO DE ASUNTOS EXTERIORES, UNIÓN EUROPEA Y COOPERACIÓN - AGENCIA ESTATAL AGENCIA ESPAÑOLA DE COOPERACIÓN INTERNACIONAL PARA EL DESARROLLO ·
Who can apply PERSONAS JURÍDICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA
International cooperation for development and culture
Period: May 29, 2026 – —
Avviso "Quota Lombardia" a sostegno delle PMI lombarde
Regione Lombardia · Lombardia
Who can apply Impresa
Cos'è La misura ha l’obiettivo di sostenere le PMI lombarde che hanno intrapreso o stanno per intraprendere un percorso di patrimonializzazione mediante la quotazione sui sistemi multilaterali di negoziazione. A chi si rivolge Possono partecipare all’iniziativa le PMI che alla data di presentazione della Domanda di contributo siano in possesso dei seguenti requisiti:- regolarmente costituite, iscritte e attive nel Registro delle Imprese alla data di presentazione della Domanda di Contributo a valere sull’Avviso;- abbiano intrapreso o intendano intraprendere un percorso per la quotazione in un MTF con un aumento di capitale pari almeno al 50% dell’offerta pubblica iniziale: nell'offerta pubblica di vendita e sottoscrizione (OPVS) l’operazione di offerta titoli deve avere ad oggetto azioni di nuova emissione per almeno il 50% dell’offerta pubblica iniziale (IPO).- non siano già quotate su sistemi multilaterali di negoziazione o mercati regolamentati europei. Cosa prevede L’agevolazione per le PMI si compone di un contributo a fondo perduto nel limite massimo di 600.000 euro per i costi relativi alla quotazione in Borsa, di cui massimo 300.000 euro per i costi legati all’ammissione alla quotazione e 300.000 euro per i costi dei servizi di consulenza correlati alla quotazione, sostenuti nei tre anni successivi alla quotazione.
Period: Jan 16, 2025 – —
Demonstration of hydropower technologies for efficient and forward-looking refurbishment of existing hydropower plants
European Union · EU
Demonstration of hydropower technologies for efficient and forward-looking refurbishment of existing hydropower plants
Period: Aug 4, 2027 – —
Industrial processes and equipment for innovative, reliable and scalable tandem technologies (EUPI-PV Partnership)
European Union · EU
Industrial processes and equipment for innovative, reliable and scalable tandem technologies (EUPI-PV Partnership)
Period: Aug 4, 2027 – —
PV based electrification of the economy: Designing & optimising PV systems supporting industrial electrification and promoting participation in electricity markets (EUPI-PV Partnership)
European Union · EU
PV based electrification of the economy: Designing & optimising PV systems supporting industrial electrification and promoting participation in electricity markets (EUPI-PV Partnership)
Period: Aug 4, 2027 – —
Advanced TSO control rooms to enhance grid observability, stability and resilience
European Union · EU
Advanced TSO control rooms to enhance grid observability, stability and resilience
Period: Aug 4, 2027 – —
Advanced Distribution Management Systems (ADSM) for more efficient and flexible distribution grids
European Union · EU
Advanced Distribution Management Systems (ADSM) for more efficient and flexible distribution grids
Period: Aug 4, 2027 – —
Integrated Approaches for Retrofitting Infrastructures with Innovative Energy Storage Technologies
European Union · EU
Integrated Approaches for Retrofitting Infrastructures with Innovative Energy Storage Technologies
Period: Aug 4, 2027 – —
Community of practice - Data-Driven Decision-Making in Energy
European Union · EU
Community of practice - Data-Driven Decision-Making in Energy
Period: Aug 4, 2027 – —
Delivery of industrial CCUS clusters – Societal Readiness pilot
European Union · EU
Delivery of industrial CCUS clusters – Societal Readiness pilot
Period: Aug 4, 2027 – —
Mass customisation of offsite manufactured modular construction components to transform the existing built environment
European Union · EU
Mass customisation of offsite manufactured modular construction components to transform the existing built environment
Period: May 5, 2027 – —
Innovative models for collective community investment and ownership
European Union · EU
Innovative models for collective community investment and ownership
Period: May 5, 2027 – —
Check whether your organisation is eligible
Create your profile and Captaru scores every call against your organisation, sector and region. It also helps you draft the application.